re|vision

Forum  /  Comparison

Charcot reconstruction

Beam it, frame it, or both — and who holds up to weightbearing.

Starting point, not a verdict

Drafted from the published literature and machine-assisted, then checked so that every citation resolves to a real indexed paper. It has not yet been reviewed by a clinician. Treat it as a starting point for the discussion, not as guidance.

Indication

Charcot neuroarthropathy with unstable midfoot or hindfoot deformity that has failed or is unlikely to respond to offloading alone. The decision point divides surgeons between internal fixation (beaming/superconstruct), circular external fixation, hybrid constructs, and continued non-operative management with total contact casting (TCC). Choice depends on deformity location, soft-tissue envelope, infection status, and patient factors.

The techniques

  • Internal beaming / superconstruct: Retrograde intramedullary nails or plates spanning the medial and lateral columns (and hindfoot when indicated) to achieve rigid compression across the deformity.
  • Circular external fixation: Ring fixators with tensioned wires or half-pins allowing gradual correction and offloading without internal hardware.
  • Combined (hybrid) fixation: Internal implants supplemented by a circular frame, typically for severe instability or concurrent infection.
  • Non-operative total contact casting (TCC): Serial, well-moulded casts changed weekly to biweekly to offload the foot and control deformity progression during the active inflammatory phase.

What the evidence says

A systematic review comparing internal versus external fixation for midfoot Charcot found internal fixation associated with 25% higher odds of functional ambulation (OR 1.26) and 42% lower ulcer occurrence (OR 0.58), but external fixation had an 8-fold higher radiographic nonunion rate (OR 8.2) [1]. Internal fixation carried a 1.5-fold increase in amputation (OR 1.49), 2-fold increase in deep infection (OR 2.07), 3.4-fold increase in wound-healing complications (OR 3.41), and 20% more unplanned reoperations [1]. In hindfoot/ankle Charcot, a single-arm meta-analysis reported lower fusion with external fixation (68%, 95% CI 56–80%) versus internal (85%, 76–93%) or hybrid (86%, 75–94%) constructs; amputation rates were numerically higher with external fixation (8.1%, 2.3–16%) than internal (4.5%, 1.0–9.7%) or hybrid (2.9%, 0–13%) [2]. Hardware removal rates were 13% for intramedullary nails, 0.7% for external fixators, and 5% for combined fixation; deep infection was 3% (nails), 3% (external), and 11% (combined); wound dehiscence was 6% (nails) and 22% (combined) [3]. A meta-analysis of ankle arthrodesis found intramedullary nails trended toward higher fusion and faster healing with significantly lower hardware and wound infection than external fixation [4]. For internal fixation overall, deep infection proportion was 6.7% (4.2–9.2%) and nonunion 11.9% (6.6–18.1%) [5]. A radiographic review noted that beaming both medial and lateral columns is necessary to prevent lateral column recurrence [6]. Non-operatively, TCC alone achieved median remission at 16.8 weeks; adding anti-resorptive or anti-inflammatory drugs did not significantly shorten time to remission [7]. A cost-effectiveness model found no widely adopted algorithm, with US payer decisions driven by surgeon preference [8].

What members see

Members who use superconstructs for midfoot Charcot: what is your observed hardware removal rate compared with the 13% reported for intramedullary nails in a recent comparative review [3]? For those using circular frames: do your pin-tract problem rates align with the 24% noted in hindfoot series [2]? How many reserve hybrid constructs for active infection, and what revision burden do you see versus the 19% revision rate reported for hybrid hindfoot cases [2]?

Cost and access

A US payer-perspective Markov model compared reconstruction, primary transtibial amputation, and lifetime bracing but did not publish per-procedure cost breakdowns in the abstract [8]. Cost drivers mentioned across the literature include implant and frame hardware expense, operating-room time, need for staged hardware removal (especially with internal fixation), pin-site care visits for external fixation, serial casting materials and clinic visits for TCC, and advanced imaging for surveillance.

Open questions

  • What is the fusion rate for midfoot superconstructs that beam both columns versus single-column fixation?
  • Does hybrid fixation truly reduce amputation in infected Charcot, or does the 23% infection rate in hindfoot hybrid cohorts [2] reflect case selection?
  • What is the long-term (>5 year) reoperation rate after successful TCC remission without surgery?
  • How do outcomes differ between retrograde nail and plate-based superconstructs for the same deformity pattern?
  • Is there a role for adjuvant bisphosphonate therapy after surgical reconstruction to reduce nonunion, given the BMC increase seen with zoledronate in active Charcot [9]?

References

9 of 15 papers retrieved for this room are cited above. The search was limited to systematic reviews, meta-analyses and randomised trials in humans, English, 2016 onwards. Query and full result set: research/raw/charcot.json.

  1. 1Internal Versus External Fixation of Charcot Midfoot Deformity Realignment. Orthopedics 2016 · PMID 27280625 Systematic Review
  2. 2Outcomes of Internal, External, and Hybrid Fixation in Hindfoot Charcot Neuroarthropathy: A Descriptive Systematic Review and Single-Arm Meta-analysis of Observational Studies. Foot Ankle Int 2026 · PMID 41589082 Systematic Review, Meta-Analysis
  3. 3Comparative Analysis of Secondary Outcomes in Treatment of Charcot Neuropathy: A Systematic Review. Foot Ankle Spec 2025 · PMID 35778875 Systematic Review
  4. 4Intramedullary nail versus external fixator for ankle arthrodesis in Charcot neuroarthropathy: A meta-analysis of comparative studies. J Orthop Surg (Hong Kong) 2019 · PMID 30894064 Meta-Analysis, Review
  5. 5Deap-seated infection and nonunion following internal fixation for Charcot foot deformity correction. A proportional meta-analysis of level 4 evidence. J Orthop Sci 2025 · PMID 38548584 Meta-Analysis
  6. 6A Systematic Review of Angular Deformities in Charcot Neuroarthropathy. J Foot Ankle Surg 2021 · PMID 33423885 Systematic Review
  7. 7Efficacy of medical treatment for Charcot neuroarthropathy: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol 2021 · PMID 33439331 Meta-Analysis, Systematic Review
  8. 8Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective? Clin Orthop Relat Res 2020 · PMID 32694315 Systematic Review
  9. 9Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus. PLoS One 2021 · PMID 34748565 Randomized Controlled Trial

Back to the comparisons